Bill > A02317

This bill prohibits health care plans from making certain changes to their prescription drug formularies during a contract year. Specifically, it prohibits plans from removing a drug from the formulary, moving a drug to a tier with higher cost-sharing, or adding utilization management restrictions, unless these changes occur during the open enrollment period. The bill includes exceptions that allow a plan to move a drug to a higher cost-sharing tier if a generic or interchangeable biological product is added at the same time, or to remove a drug if the FDA determines it should be removed from the market. The bill also requires plans to provide notice to policyholders of any changes to the formulary or cost-sharing requirements for the upcoming plan year, 30 days prior to the open enrollment period.

Business and Industry

https://assembly.state.ny.us/leg/?default_fld=&bn=A02317&term=2017&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y